Ingredient Directory A to Z

Ingredient label guide

TUDCA Supplements: Liver Claims, Dosage, Safety, and Label Guide

TUDCA is a taurine-conjugated bile acid used in standalone capsules and liver-support formulas. The useful label questions are the actual TUDCA amount per full serving, whether the product really lists TUDCA rather than UDCA, taurine, or a generic bile-salt blend, and whether the claim stays within the human evidence.

Also listed as: tauroursodeoxycholic acid, tauroursodeoxycholate, tauroursodiol, ursodoxicoltaurine, or tauro-ursodeoxycholic acid.

NutriDetector Editorial Team Updated Editorial Policy

A bile acid is not a general-purpose detox certificate

Tauroursodeoxycholic acid, usually shortened to TUDCA, is the taurine-conjugated form of ursodeoxycholic acid. It is a hydrophilic bile acid, not a vitamin, digestive enzyme, or hidden form of taurine. Research has examined its effects in specific hepatobiliary and neurological settings, but that does not make every retail liver, detox, gallbladder, alcohol, or bodybuilding claim evidence-based.

Older human trials reported changes in liver-enzyme or bile measurements in selected patient groups. Those are real findings, but most were small, condition-specific, and conducted under clinical supervision. They do not show that a TUDCA supplement cleanses a healthy liver, prevents damage from alcohol or anabolic steroids, or replaces medical evaluation. 1 3

Mechanism, biomarker, and clinical outcome are different claims

Descriptions such as bile-acid modulation, chemical chaperone, anti-apoptotic activity, or endoplasmic-reticulum stress belong to mechanism research. A change in a laboratory marker is a separate level of evidence. Neither automatically proves symptom relief, disease treatment, organ protection, or a better long-term outcome.

The strongest claim is narrower than the marketing

Liver enzymes and liver support

Small older trials in primary biliary cholangitis and chronic hepatitis C reported changes in biochemical markers. They did not establish a general liver-detox benefit for healthy users or the broad outcomes promoted on supplement labels. 1 3

Steroid-cycle and alcohol protection

The cited alcohol evidence is cell-line research, not a controlled human prevention trial. Human evidence has not established TUDCA as reliable protection from anabolic-steroid or alcohol-related liver injury, while anabolic-androgenic steroid use itself is documented to cause clinically important liver injury. A supplement should not be presented as permission to continue a harmful exposure or as a substitute for testing and care. 7, 9

Bile flow and gallbladder claims

A small study found changes in bile composition in people with radiolucent stones. That is not the same as proving reliable stone dissolution, clearing a blocked bile duct, or routine benefit after gallbladder removal. 4

ALS, brain, and eye claims

A small ALS pilot was encouraging, but a larger phase 3 trial did not meet its primary endpoint or show significant secondary benefits. Eye-protection claims remain largely preclinical and should not be marketed as established treatment. 5 6 8

Related names are not interchangeable ingredients

TUDCA and UDCA are chemically related, and a small crossover study compared equal 500 mg daily doses in primary biliary cholangitis. No significant difference in the measured liver-enzyme outcomes was found during the short study periods. That comparison does not make their label names or milligram amounts interchangeable. 2

Taurine is one component of the TUDCA molecule, but a separate taurine line is not a TUDCA dose. Generic ox bile and bile-salt blends can contain different bile acids and should not be treated as unnamed TUDCA.

What each identity line actually establishes

TUDCA or tauroursodeoxycholic acid
This is the ingredient covered by this guide. The amount should be assigned directly to TUDCA on the Supplement Facts panel.
UDCA, ursodeoxycholic acid, or ursodiol
A related bile acid with its own clinical and regulatory context. It should not be relabeled or counted as TUDCA.
Taurine
A separate amino sulfonic acid. Adding taurine milligrams to TUDCA milligrams creates a misleading TUDCA total.
Ox bile or bile salts
A broad ingredient description, not evidence of a particular TUDCA amount. Look for a separate named TUDCA line.
Vegan, synthetic, or animal-free TUDCA
A sourcing claim. The wording does not independently verify the manufacturing route, identity, purity, or batch quality.

Find the TUDCA amount before judging the liver claim

Start with serving size, then find the amount assigned to the TUDCA line. Keep that per-serving number separate from suggested-use directions, the total mass of a liver-support blend, and the amounts of taurine, NAC, milk thistle, or other co-ingredients.

Five label lines that require different interpretations

TUDCA (Tauroursodeoxycholic Acid) 500 mg
The ingredient and amount per listed serving are clear. This still does not prove purity, source, or a promised liver outcome.
TUDCA 500 mg, serving size 2 capsules
The two capsules together provide the listed 500 mg serving. It is not 500 mg per capsule unless the label says so.
TUDCA 250 mg, suggested use twice daily
The Supplement Facts amount remains 250 mg per listed serving. Directions may imply two servings, but they do not change the meaning of the per-serving line.
TUDCA 250 mg plus Taurine 500 mg
These are separate ingredients. The formula contains 250 mg of disclosed TUDCA, not 750 mg of TUDCA.
Liver Support Proprietary Blend 1,000 mg
If TUDCA appears inside the blend without its own amount, the 1,000 mg total is not the individual TUDCA dose.

Purity and source claims need their own evidence

Front-label statements such as “99% pure,” “pharmaceutical grade,” “vegan,” or “third-party tested” are not substitutes for a clear Supplement Facts line. If sourcing or purity matters, look for specific, batch-linked documentation rather than treating the slogan itself as verification.

A longer liver formula is not automatically a stronger one

TUDCA often appears beside milk thistle, NAC, glutathione, taurine, choline, artichoke or ox bile. These ingredients are not interchangeable and should not be converted into one combined TUDCA or liver-support dose.

Across multiple supplements, compare disclosed TUDCA wording, amounts, serving context, blend transparency, and co-ingredients. Keep TUDCA, taurine, UDCA, ox bile, and other bile-support ingredients separate rather than converting them into one implied TUDCA total.

A practical stack review

Standalone TUDCA
Compare the named TUDCA amount per full serving and the number of servings suggested per day.
Liver-support combinations
Keep TUDCA, milk thistle, NAC, glutathione, and other actives as separate disclosed ingredients.
Bile-support products
Distinguish TUDCA from UDCA, ox bile, generic bile salts, digestive enzymes, and taurine.
Hidden blend amounts
Keep the TUDCA dose uncertain when the label gives only a total blend weight and a component list.

Study doses belong to their study, not every supplement goal

Human studies have used markedly different daily amounts. A small six-month dose-response study in primary biliary cholangitis used 500, 1,000, or 1,500 mg per day. A chronic hepatitis C trial used 500 or 750 mg per day, while the small ALS pilot used 1,000 mg twice daily. These amounts came from specific clinical protocols and do not establish a universal retail dose for liver support, detox, alcohol recovery, gallstones, or neurological protection. 1 3 5

Put the number in context

250 mg per serving
A common commercial amount, not proof of an effective dose for every advertised purpose.
500 to 1,500 mg per day
Used across older condition-specific liver studies; the participants, outcomes, and supervision limit how broadly those numbers can be applied.
2,000 mg per day
Used in the small ALS pilot and later ALS research; it is not a general supplement target or evidence of benefit for other outcomes.
No established supplement upper limit
The absence of a formal upper limit is not evidence that any dose, duration, or combination is safe.

Meal timing is less settled than marketing suggests. The human studies cited on this page do not establish a universal rule that TUDCA must be taken with food or with a fatty meal to work. Follow the product directions and keep the per-serving amount separate from the daily schedule.

Liver and biliary symptoms need more than a supplement label

Gastrointestinal effects, including diarrhea or loose stools, are among the recurring tolerance issues in human TUDCA research. However, the condition-specific trials cited here do not establish long-term safety across all populations, medical conditions, doses, or commercial formulations. Short-term or trial-specific tolerability should not be treated as proof that prolonged or unsupervised high-dose use is suitable for everyone. 5, 6

Known liver or biliary disease, suspected obstruction, persistent gallbladder symptoms, prescription bile-acid therapy, abnormal liver tests, or significant alcohol or anabolic-steroid exposure change the context. TUDCA should not be used to delay evaluation or mask a potentially serious problem.

Common marketing shortcuts

Be cautious with claims that TUDCA “detoxes” the liver, makes alcohol or oral steroids safe, dissolves every gallstone, is automatically needed after gallbladder removal, reverses ALS, or protects eyesight. Also treat “pharmaceutical grade” and fixed purity percentages as claims that need specific product documentation rather than proof supplied by the phrase alone.

How NutriDetector reads TUDCA labels

The analysis checks supported TUDCA wording, the disclosed amount and unit, serving context, blend transparency, and the surrounding formula. It recognizes supported names such as tauroursodeoxycholic acid, tauroursodiol, and ursodoxicoltaurine, keeps TUDCA separate from taurine, and does not treat a total proprietary-blend weight as an individual TUDCA dose.

The result is limited to the submitted label. It cannot laboratory-test chemical identity, actual TUDCA content, bile-acid impurities, purity, contaminants, manufacturing route, or batch consistency, assess liver, gallbladder, or bile-duct status, establish clinical benefit, clear medicine interactions, or decide personal suitability. Compare extracted details with the original Supplement Facts panel before using the interpretation.

Analyze the full formula

Check the TUDCA amount behind the liver claim.

NutriDetector keeps disclosed TUDCA amounts, supported identity wording, serving context, blend transparency, and co-ingredients separate so unlike bile-support ingredients and hidden blend totals are not treated as equivalent across the full formula.

Analyze a supplement label

TUDCA supplement FAQ

What does TUDCA do?

TUDCA is a taurine-conjugated bile acid. Human research has examined biochemical and clinical outcomes in specific liver and neurological settings, while laboratory research describes effects on bile-acid handling, cell stress, and apoptosis. Those findings do not prove that a retail supplement detoxes a healthy liver or delivers every marketed outcome.

Is TUDCA the same as UDCA?

No. TUDCA is the taurine-conjugated form of ursodeoxycholic acid, so the compounds are related but not identical label ingredients. A small crossover study found no significant difference in measured liver-enzyme outcomes between equal 500 mg daily doses, but their names and milligram amounts should still be kept separate.

Does TUDCA detox or repair the liver?

Older condition-specific trials reported changes in liver-enzyme measurements, but they did not establish a general liver cleanse, removal of unspecified toxins, or repair of alcohol-, medicine-, or steroid-related injury in healthy supplement users. A biomarker change is not proof of a broad detox outcome.

Does TUDCA protect the liver during steroid cycles or alcohol use?

Controlled human evidence has not established TUDCA as reliable protection against anabolic-steroid or alcohol-related liver injury. Mechanism, cell, or animal findings cannot make a steroid cycle or alcohol exposure safe, and a supplement should not replace liver testing, risk reduction, or clinical care.

Does TUDCA dissolve gallstones or help after gallbladder removal?

A small study reported changes in bile composition in people with radiolucent stones, but that is not proof that supplements reliably dissolve gallstones, clear an obstruction, or are routinely needed after gallbladder removal. Gallbladder and bile-duct symptoms need individual medical assessment.

Does TUDCA help ALS?

A small placebo-controlled pilot using 1,000 mg twice daily reported encouraging findings, but the larger European phase 3 trial did not meet its primary endpoint and found no significant differences in secondary outcomes. TUDCA should not be presented as an established ALS treatment.

Does TUDCA protect eyesight?

Much of the eye-protection evidence comes from mouse models of retinal degeneration or injury. Those experiments are useful for research but do not establish that an oral TUDCA supplement prevents vision loss or treats an eye disease in people.

What dose of TUDCA was used in studies, and should it be taken with food?

Human studies have used amounts from 500 to 1,500 mg per day in older liver protocols and 2,000 mg per day in ALS research. These are condition-specific study doses, not universal supplement targets. The evidence cited here does not establish a universal rule that TUDCA must be taken with food or with a fatty meal to work.

How can you tell whether TUDCA is genuine, and what does NutriDetector check?

A label can disclose TUDCA wording, amount per listed serving, source claims, serving context, blends, and co-ingredients, but it cannot prove identity or purity by itself. NutriDetector reviews supported TUDCA names, the disclosed per-serving amount, serving context, blend transparency, and surrounding formula. Batch-linked analytical documentation is needed for stronger identity and purity assurance.

Scientific references and safety sources
  1. Crosignani A, et al. Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis: a dose-response study. Digestive Diseases and Sciences. 1996;41(4):809-815. PubMed.
  2. Larghi A, et al. Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study. Alimentary Pharmacology & Therapeutics. 1997;11(2):409-414. PubMed.
  3. Crosignani A, et al. Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study. Hepatogastroenterology. 1998;45(23):1624-1629. PubMed.
  4. Muraca M, et al. Effect of tauroursodeoxycholic acid on biliary lipid composition: a dose-response study. International Journal of Clinical Pharmacology and Therapeutics. 1995;33(7):391-393. PubMed.
  5. Elia AE, et al. Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. European Journal of Neurology. 2016;23(1):45-52. PubMed.
  6. TUDCA-ALS Consortium. Announcement of top-line results from the European phase 3 TUDCA-ALS trial. Published March 27, 2024. TUDCA-ALS Consortium.
  7. Neuman MG, et al. Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell line. Gastroenterology. 1995;109(2):555-563. PubMed.
  8. Boatright JH, et al. Tool from ancient pharmacopoeia prevents vision loss. Molecular Vision. 2006;12:1706-1714. PubMed.
  9. Robles-Diaz M, et al. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Alimentary Pharmacology & Therapeutics. 2015;41(1):116-125. PubMed.